JP2009542243A5 - - Google Patents

Info

Publication number

JP2009542243A5

JP2009542243A5 JP2009518907A JP2009518907A JP2009542243A5 JP 2009542243 A5 JP2009542243 A5 JP 2009542243A5 JP 2009518907 A JP2009518907 A JP 2009518907A JP 2009518907 A JP2009518907 A JP 2009518907A JP 2009542243 A5 JP2009542243 A5 JP 2009542243A5

Authority

JP

Japan

Prior art keywords

seq

acid sequence

polypeptide

nucleic acid

protein

Prior art date

2007-07-12

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 claims 33
• 150000007523 nucleic acids Chemical class 0.000 claims 19
• 229920001184 polypeptide Polymers 0.000 claims 18
• 102000004196 processed proteins & peptides Human genes 0.000 claims 18
• 125000003275 alpha amino acid group Chemical group 0.000 claims 16
• 102000004169 proteins and genes Human genes 0.000 claims 16
• 108090000623 proteins and genes Proteins 0.000 claims 16
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 9
• 108020004707 nucleic acids Proteins 0.000 claims 9
• 102000039446 nucleic acids Human genes 0.000 claims 9
• 239000012634 fragment Substances 0.000 claims 7
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
• 238000000034 method Methods 0.000 claims 5
• 150000001413 amino acids Chemical class 0.000 claims 4
• 239000012472 biological sample Substances 0.000 claims 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
• 241000244023 Anisakis Species 0.000 claims 2
• 102000004190 Enzymes Human genes 0.000 claims 2
• 108090000790 Enzymes Proteins 0.000 claims 2
• 239000013604 expression vector Substances 0.000 claims 2
• 238000003018 immunoassay Methods 0.000 claims 2
• 238000002372 labelling Methods 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 239000002773 nucleotide Substances 0.000 claims 2
• 125000003729 nucleotide group Chemical group 0.000 claims 2
• IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical class OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 claims 1
• 206010020751 Hypersensitivity Diseases 0.000 claims 1
• 241000244206 Nematoda Species 0.000 claims 1
• 230000007815 allergy Effects 0.000 claims 1
• 229960002685 biotin Drugs 0.000 claims 1
• 235000020958 biotin Nutrition 0.000 claims 1
• 239000011616 biotin Substances 0.000 claims 1
• 230000000295 complement effect Effects 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
• 230000001900 immune effect Effects 0.000 claims 1
• 239000004816 latex Substances 0.000 claims 1
• 229920000126 latex Polymers 0.000 claims 1
• 239000000203 mixture Substances 0.000 claims 1
• 238000000746 purification Methods 0.000 claims 1
• 230000002285 radioactive effect Effects 0.000 claims 1
• 238000005215 recombination Methods 0.000 claims 1
• 230000006798 recombination Effects 0.000 claims 1
• 239000000523 sample Substances 0.000 claims 1
• 210000002966 serum Anatomy 0.000 claims 1
• 241000894007 species Species 0.000 claims 1
• 238000003786 synthesis reaction Methods 0.000 claims 1